ICCM
IceCure Medical Ltd
NASDAQ · Healthcare · Medical - Devices · IL
$2.23
+1.36%Year over year
Reported trailing growth
- Revenue
- +41.6%
- EBITDA
- -5.8%
- EBIT
- -38.5%
- EPS
- -79.4%
- Free cash flow
- -14.9%
- Operating cash flow
- -14.9%
Forward estimates
Based on analyst estimates
- Revenue
- +35.3%
- EBITDA
- +24.5%
- EPS
- +37.7%
Three-year CAGR
- Revenue
- +3.1%
- EBITDA
- +3.7%
- EBIT
- +3.8%
- Net income
- +1.7%
- EPS
- +21.1%
- Free cash flow
- -15.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026